Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial

• Glavni autori: Rebecca M. Reynolds (Autor), Fiona C. Denison (Autor), Ed Juszczak (Autor), Jennifer L. Bell (Autor), Jessica Penneycard (Autor), Mark W. J. Strachan (Autor), Robert S. Lindsay (Autor), Claire I. Alexander (Autor), Corinne D. B. Love (Autor), Sonia Whyte (Autor), Fiona Mackenzie (Autor), Ben Stenson (Autor), Jane E. Norman (Autor)
• Format: Knjiga
• Izdano: BMC, 2017-09-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Abstract Background Metformin is widely used to treat gestational diabetes (GDM), but many women remain hyperglycaemic and require additional therapy. We aimed to determine recruitment rate and participant throughput in a randomised trial of glibenclamide compared with standard therapy insulin (adde...